5500 - J&J Procurement_Suppliers_FINAL_WEB.mp4
- Home
- Our company
- Suppliers
Suppliers
Just as we believe that good health is the foundation of vibrant lives, thriving communities and forward progress, at Johnson & Johnson we also pride ourselves on fostering healthy supplier relationships that are built on trust, transparency and unparalleled innovation, quality and reliability.
Working with our valued partners, we uphold the highest standards for responsible sourcing and corporate citizenship, encouraging our suppliers to embrace new technologies, source innovative solutions and deliver new business models that contribute to our mutual objectives for growth, sustainability and streamlined processes.
Expand
Collapse
Featured stories
How Johnson & Johnson is helping people displaced by war and conflict restart their lives
A Partnership for Good program expands the company’s talent pool in Europe while assisting the mental and financial health of people displaced by conflict. Here’s how this novel initiative helped one young Ukraine War refugee get a foothold.
Turning our supplier spend into societal good
Johnson & Johnson’s Global Supplier Diversity & Inclusion team is stepping up spending with social enterprises around the world to deepen its impact in local communities.
Securing the future of surgery, one staple at a time
Faced with the challenge of improving stapling performance for consistent outcomes in challenging tissue, Ethicon drew inspiration from its broad and talented supplier base.
More from Johnson & Johnson
Meet two Johnson & Johnson nurse educators dedicated to teaching cancer care providers
Jennifer Huff and Jacqui Mellott are two of Johnson & Johnson’s oncology clinical educators—a team of 56 nurses who visit hospitals and infusion centers to help providers understand and stay up to date with treatments.
5 things we now know about plaque psoriasis
Plaque psoriasis is the most prevalent form of psoriasis, affecting millions worldwide. Johnson & Johnson is focused on developing novel therapies for chronic dermatologic diseases to address the unmet need that still exists.
Getting in front of cancer
Every year, roughly 2 million people in the U.S. are newly diagnosed with cancer. But new scientific breakthroughs—including ones made at Johnson & Johnson—have dramatically changed the prognosis of many of these patients.